Most cited papers from Telesage (United States)

Telesage (United States)

What are the most cited papers from Telesage (United States)?

The most cited paper from Telesage (United States) is "Validation of the NetSCID: an automated web-based adaptive version of the SCID" (Benjamin B. Brodey, Michael B. First, Jared Linthicum et al., 2015), with 61 citations. Next come "RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS" (42) and "The acceptability and effectiveness of patient-reported assessments and feedback in a managed behavioral healthcare setting." (41).

Published TypeFieldAccess

Showing 50 of 71 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Validation of the NetSCID: an automated web-based adaptive version of the SCID Benjamin B. Brodey, Michael B. First, Jared Linthicum et al. · Comprehensive Psychiatry Open access	7 Nov 2015	61
2	RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS Vineet Bhandari, Rachel M. Black, Bheru B. Gandhi et al. · Journal of Perinatology Open access	15 May 2023	42
3	The acceptability and effectiveness of patient-reported assessments and feedback in a managed behavioral healthcare setting. Benjamin B. Brodey, Brian J. Cuffel, Joyce McCulloch et al. · PubMed	Dec 2005	41
4	Validation of the Addiction Severity Index (ASI) for internet and automated telephone self-report administration Benjamin B. Brodey, Craig S. Rosen, Inger Sigrun Brodey et al. · Journal of Substance Abuse Treatment Open access	Jun 2004	40
5	Rapid and Accurate Behavioral Health Diagnostic Screening: Initial Validation Study of a Web-Based, Self-Report Tool (the SAGE-SR) Benjamin B. Brodey, Susan E. Purcell, Karen Rhea et al. · Journal of Medical Internet Research Open access	23 Mar 2018	38
6	Distinct and shared contributions of diagnosis and symptom domains to cognitive performance in severe mental illness in the Paisa population: a case-control study Susan K. Service et al. · The Lancet Psychiatry Open access	27 Apr 2020	35
7	Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109 Kevin W. Garey, Jinhee Jo, Anne J Gonzales-Luna et al. · JAMA Network Open Open access	30 Jan 2023	30
8	Conversion and Validation of the Teen-Addiction Severity Index (T-ASI) for Internet and Automated-Telephone Self-Report Administration. Benjamin B. Brodey, Craig S. Rosen, Ken C. Winters et al. · Psychology of Addictive Behaviors	Mar 2005	26
9	A systematic review of real-world healthcare resource use and costs of Clostridioides difficile infections Daniel C. Malone, Edward P. Armstrong, Dan Gratie et al. · Antimicrobial Stewardship & Healthcare Epidemiology ReviewOpen access	2023	24
10	Development of the Perinatal Depression Inventory (PDI)-14 using item response theory: a comparison of the BDI-II, EPDS, PDI, and PHQ-9 Benjamin B. Brodey, Sherryl Hope Goodman, Ruth E. Baldasaro et al. · Archives of Women s Mental Health Open access	13 Aug 2015	24
11	Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study Eugene R. Bleecker, Michael S. Blaiss, Juby Anne Jacob-Nara et al. · Journal of Allergy and Clinical Immunology Open access	24 Aug 2024	23
12	Real-world effectiveness of dupilumab in patients with asthma Michael S. Blaiss, Eugene R. Bleecker, Juby Anne Jacob-Nara et al. · Annals of Allergy Asthma & Immunology	14 Nov 2023	21
13	The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning B.B. Brodey, Ragy R. Girgis, Oleg V. Favorov et al. · Schizophrenia Research Open access	19 Jan 2018	20
14	Patient Experiences with Clostridioides difficile Infection and Its Treatment: A Systematic Literature Review Edward P. Armstrong, Daniel C. Malone, Duska M. Franic et al. · Infectious Diseases and Therapy ReviewOpen access	Jul 2023	17
15	The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning Benjamin B. Brodey, Ragy R. Girgis, Oleg V. Favorov et al. · Schizophrenia Research Open access	15 Feb 2019	16
16	Reliability and Acceptability of Automated Telephone Surveys Among Spanish- and English-Speaking Mental Health Services Recipients Benjamin B. Brodey, Craig S. Rosen, Inger Sigrun Brodey et al. · Mental Health Services Research	15 Jul 2005	16
17	Monitoring Patient Improvement and Treatment Outcomes in Managed Behavioral Health Francisca Azocar, Brian J. Cuffel, Joyce McCulloch et al. · Journal for Healthcare Quality	Mar 2007	16
18	Psychometric Characteristics of the Teen Addiction Severity Index-Two (T-ASI-2) Benjamin B. Brodey, Darcy McMullin, Yifrah Kaminer et al. · Substance Abuse	Mar 2008	15
19	Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States Andrew P. Brogan, S. Hogue, Renu M. Vekaria et al. · Journal of Managed Care & Specialty Pharmacy Open access	28 Nov 2019	14
20	Assessing the Equivalence of Paper, Mobile Phone, and Tablet Survey Responses at a Community Mental Health Center Using Equivalent Halves of a ‘Gold-Standard’ Depression Item Bank Benjamin B. Brodey, Nicole Gonzalez, Kathryn Ann Elkin et al. · JMIR Mental Health Open access	6 Sep 2017	14
21	Ab interno minimally invasive glaucoma surgery combined with cataract surgery and cataract surgery alone: IRIS® registry study Michael Mbagwu, Richard A. Chapman, Kristian Garcia et al. · AJO International Open access	7 Apr 2024	13
22	Adherence and usage patterns of inhaled corticosteroids‐long-acting beta-agonists by using inhaler-monitoring technology Richard H. Stanford, Carlyne M. Averell, Phaedra T. Johnson et al. · Allergy and Asthma Proceedings	Jul 2020	13
23	Validation and Assessment of the COPD Treatment Ratio as a Predictor of Severe Exacerbations Richard H. Stanford, Stephanie Korrer, Lee N. Brekke et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access	2020	12
24	The Early Psychosis Screener (EPS): Item development and qualitative validation Benjamin B. Brodey, Jean Addington, Michael B. First et al. · Schizophrenia Research Open access	16 Dec 2017	12
25	Patient-Reported Outcome Measure Development and Validation: A Primer for Clinicians Mark R. Kosinski, Linda M Nelson, Richard H. Stanford et al. · The Journal of Allergy and Clinical Immunology In Practice	23 Aug 2024	11
26	Real-world effectiveness of dupilumab versus benralizumab and mepolizumab Eugene R. Bleecker, Michael S. Blaiss, Juby Anne Jacob-Nara et al. · Allergy and Asthma Proceedings	18 May 2024	11
27	Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization and Mortality: A Systematic Literature Review Ashley S. Cha-Silva, Meghan B. Gavaghan, Tobias Bergroth et al. · American Journal of Therapeutics ReviewOpen access	29 Apr 2024	11
28	Validation of a Health-Related Quality of Life Questionnaire in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Phase 3 Randomized Trial Brittany R. Lapin, Kevin W. Garey, Henry Wu et al. · Clinical Infectious Diseases	5 Jul 2022	11
29	The Zero-Price Conundrum: Exploration of Scenarios Where a Clinically Effective New Drug Might Not Be Cost-Effective at Zero Price Deirdre M. Mladsi, Christine L. Barnett, Gregory Mader et al. · Value in Health Open access	25 Jan 2023	10
30	Impact of Food Allergy on the Atopic March Progression From Atopic Dermatitis in Early Childhood to Other Atopic Disorders at School Age Robert S. Zeiger, Michael N. Schatz, Botao Zhou et al. · The Journal of Allergy and Clinical Immunology In Practice Open access	8 May 2025	7
31	Psychometric properties of the Asthma Control Test in 2 randomized clinical trials Mark R. Kosinski, Linda M. Nelsen, Avery A. Rizio et al. · The Journal of Allergy and Clinical Immunology In Practice Open access	6 Aug 2020	6
32	Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGE Giorgio Walter Canonica, Johann Christian Virchow Jr., Arnaud Bourdin et al. · ERJ Open Research Open access	13 Mar 2025	5
33	Adolescent Substance Use Assessment in a Primary Care Setting Benjamin B. Brodey, Darcy McMullin, Ken C. Winters et al. · The American Journal of Drug and Alcohol Abuse	2007	5
34	Burden of hypereosinophilic syndromes in the United States: Patients’ perspective Jared Silver, Anna Kovalszki, Mary Jo Strobel et al. · Journal of Allergy and Clinical Immunology Global Open access	28 May 2025	3
35	Budget impact analysis (BIA) of the TearCare System for the treatment of meibomian gland dysfunction (MGD)-associated dry eye disease (DED) in the United States (US) Thomas M. Chester, Roberta Luiza Longo, Cristina Masseria et al. · Expert Review of Ophthalmology Open access	19 Dec 2024	3
36	The budget impact of introducing the OMNI® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma Gregory Mader, Federico Ghinelli, Francesca Torelli et al. · Expert Review of Pharmacoeconomics & Outcomes Research	24 May 2023	3
37	OMNI® surgical system versus iStent inject® with concomitant cataract surgery for the treatment of mild-to-moderate primary open-angle glaucoma in the United States: a cost utility analysis Roberta Luiza Longo, Federico Ghinelli, Francesca Torelli et al. · Expert Review of Ophthalmology	4 Mar 2023	3
38	Machine learning prediction of asthma and allergic rhinitis in children with early-onset atopic dermatitis Wansu Chen, Botao Zhou, Michael Schatz et al. · Journal of Allergy and Clinical Immunology	17 Apr 2026	2
39	Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control – a retrospective United States database analysis Nicola Alexander Hanania, Richard H. Stanford, Adrián Rendón et al. · Respiratory Medicine Open access	28 May 2025	2
40	Assessment of clinical characteristics and mortality in patients hospitalized with SARS-CoV-2 from January 2022 to November 2022, when Omicron variants were predominant in the United States Amie M. D. Scott, Laura Puzniak, Michael V. Murphy et al. · Current Medical Research and Opinion Open access	2 Jan 2025	2
41	A Systematic Literature Review of Clinical Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated in the Third-Line or Later Setting Sarah Bandy, Amy D. Wu, Daniel Gratie et al. · Blood ReviewOpen access	5 Nov 2024	2
42	Early Impact of Eptinezumab on the Health-Related Quality of Life (HRQoL) of Patients with Episodic or Chronic Migraine: SF-36 Analysis Across the Spectrum of Migraine (P1.10-025) Merle L. Diamond, Richard B. Lipton, Ruslan V. Horblyuk et al. · Neurology	9 Apr 2019	2
43	Eptinezumab Meaningfully Improves Quality of Life (QoL) in Patients with Episodic or Chronic Migraine Within 1 Month After Treatment (P2.10-007) Egilius L.H. Spierings, Abraham Jim Nagy, Roger K. Cady et al. · Neurology	9 Apr 2019	2
44	RWD70 Comprehensive Code List Associated with CDC-Defined High-Risk Underlying Medical Conditions Leading to Potential Progression to Severe COVID-19 Outcomes Amie M. D. Scott, Florin Draica, J. Atkinson et al. · Value in Health Open access	Jun 2023	2
45	Examining rural community pharmacists’ knowledge and practices in opioid overdose prevention and treatment services in the Southeastern United States Stefanie P. Ferreri, Paige Q. Ngo, Kaileigh D. Yen et al. · Harm Reduction Journal Open access	13 Dec 2025	1
46	Identifying Treatable Traits of Patients with Asthma Prescribed an ICS/LABA: A Descriptive Analytic Database Study in England Jennifer Kathleen Quint, Adrián Rendón, Richard H. Stanford et al. · Advances in Therapy Open access	19 Aug 2025	1
47	TearCare system versus cyclosporine ophthalmic emulsion for the treatment of moderate-to-severe meibomian gland disease associated dry eye disease in the United States: a cost-utility analysis Nathan Lighthizer, Bonnie-Kim Schwertz, Thomas M. Chester et al. · Expert Review of Pharmacoeconomics & Outcomes Research Open access	24 Jul 2025	1
48	516. A Systematic Literature Review Evaluating Real-World Use of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Death Ashley S. Cha-Silva, Meghan B. Gavaghan, Jennifer L. Nguyen et al. · Open Forum Infectious Diseases ReviewOpen access	27 Nov 2023	1
49	522. Real-World, Retrospective Descriptive Study of COVID-19 Outpatient Therapeutic Uptake in High-Risk Patients Subsequently Hospitalized for COVID-19 During the Omicron Period in the US Amie M. D. Scott, Laura Puzniak, Michael V. Murphy et al. · Open Forum Infectious Diseases Open access	27 Nov 2023	1
50	Real-World Botulinum Toxin Type A Treatment Patterns in Patients With Cervical Dystonia Daniel Gratie, Daniel W. Mercer, Jae Hyun Lee et al. · Toxicon	Jul 2022	1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.